LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000546.6:c.820G>T
TP53
· NP_000537.3:p.(Val274Phe)
· NM_000546.6
GRCh37: chr17:7577118 C>A
·
GRCh38: chr17:7673800 C>A
Gene:
TP53
Transcript:
NM_000546.6
Final call
Likely Pathogenic
PS3 strong
PM2 supporting
PP3 supporting
Variant details
Gene
TP53
Transcript
NM_000546.6
Protein
NP_000537.3:p.(Val274Phe)
gnomAD AF
6.195418364211298e-07 (v4.1)
ClinVar
Pathogenic
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PS3 (Strong): non-functional in the Kato assay and loss-of-function in the Funk, Giacomelli, and Kotler assays per the TP53 VCEP functional worksheet.
2
PM2 (Supporting): essentially absent from population databases, with gnomAD v4.1 total allele frequency 6.2e-07, below the 0.00003 threshold.
3
PP3 (Supporting): the VCEP per-variant table assigns PP3 on Align-GVGD class C45 and BayesDel 0.315825.
4
Overall: Likely Pathogenic, from PS3 strong (+4) + PM2 supporting (+1) + PP3 supporting (+1) = 6 points in the TP53 VCEP v2.4 framework.
Final determination:
Under the TP53 VCEP v2.4 point-based framework, a total of 6 points maps to Likely Pathogenic.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Not met | Not met: missense change with no premature stop, frameshift, or splice effect (SpliceAI max delta 0.00). |
cspec
spliceai
|
| PS1 | Not assessed | Not assessed: no previously established pathogenic or likely pathogenic variant producing the same p.Val274Phe change is available. |
cspec
pm5_candidates
spliceai
|
| PS2 | Not assessed | Not assessed: no confirmed de novo observation with parental testing and maternity/paternity confirmation was available. |
cspec
PMID:31775759
|
| PS3 | Met | Met (Strong): non-functional in the Kato assay and loss-of-function in the Funk, Giacomelli, and Kotler assays per the VCEP worksheet. |
cspec
vcep_flowchart_for_application_of_functional_rule_codes
vcep_functional_worksheet
|
| PS4 | Not assessed | Not assessed: no qualifying germline proband observations; the only variant report is tumor-only. |
cspec
|
| PM1 | Not assessed | Not assessed: residue 274 is outside the VCEP PM1 codon list (175, 245, 248, 249, 273, 282). |
cspec
|
| PM2 | Met | Met (Supporting): gnomAD v4.1 total allele frequency 6.2e-07 (1/1,614,096 alleles), below the 0.00003 threshold. |
cspec
gnomad_v4
gnomad_v2
gnomad_canada
|
| PM3 | N/A | Not applicable: PM3 does not apply to TP53, which the VCEP treats as an autosomal dominant disorder. |
cspec
|
| PM4 | N/A | Not applicable: missense substitution with no protein-length change. |
cspec
|
| PM5 | Not assessed | Not assessed: no different pathogenic or likely pathogenic missense variant at residue 274 is available as a comparator. |
cspec
pm5_candidates
spliceai
|
| PM6 | N/A | Not applicable: PM6 is dropped under the TP53 VCEP; de novo evidence is scored exclusively by PS2. |
cspec
|
| PP1 | Not assessed | Not assessed: no affected relatives or countable meioses in families with LFS-associated cancers were available. |
cspec
PMID:31775759
|
| PP2 | N/A | Not applicable: PP2 is not permitted for TP53 under the VCEP specifications. |
cspec
|
| PP3 | Met | Met (Supporting): the VCEP per-variant table assigns PP3 based on Align-GVGD class C45 and BayesDel 0.315825. |
cspec
vcep_pp3_bp4_codes
spliceai
|
| PP4 | Not assessed | Not assessed: no multigene-panel tumor VAF observations (supporting requires 5-35%) were available. |
cspec
|
| PP5 | Not met | Not met: no exact-variant ClinVar expert-panel Pathogenic or Likely Pathogenic assertion is present. |
clinvar
|
| BA1 | Not met | Not met: highest ancestry allele frequency 8.5e-07 versus the >=0.001 BA1 threshold. |
cspec
gnomad_v4
|
| BS1 | Not met | Not met: highest ancestry allele frequency 8.5e-07 versus the >=0.0003 BS1 threshold. |
cspec
gnomad_v4
|
| BS2 | Not assessed | Not assessed: no qualifying carrier observations (unrelated females aged 60+ without cancer) were available. |
cspec
gnomad_v4
|
| BS3 | Not met | Not met: the VCEP worksheet records loss-of-function results for V274F, not the functional pattern BS3 requires. |
cspec
vcep_flowchart_for_application_of_functional_rule_codes
vcep_functional_worksheet
|
| BS4 | Not assessed | Not assessed: no family genotypes or segregation data were available to evaluate lack of segregation. |
cspec
PMID:31775759
|
| BP1 | N/A | Not applicable: p.Val274Phe is a missense variant, and BP1 applies only to truncating variants. |
cspec
|
| BP2 | N/A | Not applicable: BP2 is not an applicable TP53 VCEP criterion. |
cspec
|
| BP3 | N/A | Not applicable: missense substitution, not an in-frame insertion or deletion. |
cspec
|
| BP4 | Not met | Not met: the VCEP assigns pathogenic-direction PP3, not BP4, to this missense variant. |
cspec
vcep_pp3_bp4_codes
spliceai
|
| BP5 | N/A | Not applicable: BP5 is not applicable under the TP53 VCEP v2.4 specifications. |
cspec
|
| BP6 | Not met | Not met: no exact-variant ClinVar expert-panel Benign or Likely Benign assertion is present. |
clinvar
|
| BP7 | N/A | Not applicable: missense variant, not synonymous or intronic. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.